Lineage Cell Therapeutics (LCTX) Receivables - Other (2011 - 2026)
Lineage Cell Therapeutics (LCTX) reported Receivables - Other of $585000.0 for Q1 2026, down 12.82% quarter-over-quarter from $671000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Receivables - Other (2011 - 2026) Analysis & Trends
Lineage Cell Therapeutics has reported Receivables - Other for 14 years, with the latest figure at $585000.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Other changed N/A year-over-year to $585000.0; the trailing twelve-month figure through Mar 2026 stood at $585000.0 (changed N/A YoY), and the FY2025 full-year result was $671000.0, changed N/A from the prior year.
- Receivables - Other for Q1 2026 stood at $585000.0, down from $671000.0 in the prior quarter.
- The five-year high for Receivables - Other was $671000.0 in Q4 2025, with the low at $200000.0 in Q2 2022.
- Historically, Receivables - Other has averaged $521833.3 across 3 years, with a median of $565000.0 in 2022.
- The largest YoY upside for Receivables - Other was 8.6% in 2022 against a maximum downside of 8.6% in 2022.
- Lineage Cell Therapeutics' Receivables - Other stood at $581000.0 in 2022, then gained by 15.49% to $671000.0 in 2025, then retreated by 12.82% to $585000.0 in 2026.
- The last three Receivables - Other figures came in at $585000.0 (Q1 2026), $671000.0 (Q4 2025), and $549000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 585,000.00 |
| Mar 31, 2026 | 585,000.00 |
| Dec 31, 2025 | 671,000.00 |
| Dec 31, 2025 | 671,000.00 |
| Sep 30, 2025 | 549,000.00 |
| Sep 30, 2025 | 549,000.00 |
| Dec 31, 2022 | 581,000.00 |
| Dec 31, 2022 | 581,000.00 |
| Sep 30, 2022 | 545,000.00 |
| Sep 30, 2022 | 545,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Dec 31, 2021 | 535,000.00 |
| Dec 31, 2021 | 535,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Jun 30, 2020 | 7,000.00 |
| Mar 31, 2020 | 47,000.00 |
| Mar 31, 2020 | 47,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Dec 31, 2019 | 7,000.00 |